HopeStage
Back to overview

Bipolarity studies

Topics
More filters

Bipolarity

Bipolarity involves episodes of depression and periods of elevated or irritable mood, with unusually high energy and activity.

1979studies shown
Showing 1,225-1,236 of 1,979
Drug study icon
WithdrawnNCT03764683

Suvorexant (Belsomra) for Depression in bipolarity With Insomnia

Official study title

A Double-Blind Sequential Parallel Study of Suvorexant (Belsomra) for the Treatment of Bipolar Depression With Insomnia

This study was withdrawn before enrollment.

Location not clearly listed
Bipolarity, DepressionMedication studyAges 18–75
Countries
Sponsor
Massachusetts General Hospital (Hospital / academic medical center)
Behavioral study icon
CompletedNCT04450147

Tai Chi/Qigong for Subsyndromal Depression and Cognition in Older Age Bipolarity

Official study title

Efficacy of Tai Chi/Qigong for Subsyndromal Depression and Cognition in Older Age Bipolar Disorder: A Pilot Randomized Controlled Trial With an Active Control

This study has finished and is no longer accepting participants.

In Montreal
Bipolarity, DepressionBehavioural studyAges 40+
Countries
Canada
Sponsor
Lady Davis Institute
Drug study icon
CompletedNCT00044187

The Assessment of a Weight-Gain Agent for Olanzapine-Associated Anti-Obesity Agent in people with Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder, and Bipolarity type I

Official study title

The Assessment of a Anti-Obesity Agent for the Treatment of Olanzapine-Associated Weight Gain in Patients With Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder and Bipolar I Disorder

This study has finished and is no longer accepting participants.

Multiple locations, including El Centro
Bipolarity, SchizophreniaMedication studyAges 18–65
Countries
United States
Sponsor
Eli Lilly and Company
Drug study icon
CompletedNCT06429722

Effects of NMRA-335140 on Symptoms of Major Depression in people with Bipolarity type II.

What is this study about?

Researchers compared NMRA-335140 80 mg and placebo to find out how the approaches affected depression symptoms in people with bipolarity type II during a depressive episode.

This study has finished and is no longer accepting participants.

Multiple locations, including Phoenix
Bipolarity, DepressionMedication studyAges 18–65
Countries
United States
Sponsor
Neumora Therapeutics, Inc.
Device study icon
WithdrawnNCT00470639

Transcranial Magnetic Stimulation for Depression in bipolarity

Official study title

A Comparison of Left vs. Right Prefrontal Cortex Transcranial Magnetic Stimulation as a Treatment for Bipolar Depression

This study was withdrawn before enrollment.

In Sydney
Bipolarity, DepressionDevice studyAges 18–80
Countries
Australia
Sponsor
The University of New South Wales
Drug study icon
CompletedNCT01430455

Tranylcypromine Treatment of Depression in bipolarity

Official study title

Tranylcypromine Treatment of Bipolar Depression

This study has finished and is no longer accepting participants.

In New York
Bipolarity, DepressionMedication studyAges 18–65
Countries
United States
Sponsor
New York State Psychiatric Institute
Other study type icon
CompletedNCT00757328

Treatment Clinical Practice in Depression in bipolarity in Spain

Official study title

EPIDEP. Epidemiologic Study in Bipolar Depression: Evaluation of the Usual Clinical Practice of Psychiatrists in Spain

This study has finished and is no longer accepting participants.

Multiple locations, including Santander
Bipolarity, DepressionObservational studyAges 18+
Countries
Spain
Sponsor
AstraZeneca

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.